Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Growth 2022-2028

The Kidney Injury Molecule 1 (KIM-1) ELISA Kit quantifies KIM-1 concentrations in serum, plasma, and other biological fluids.
The global market for Kidney Injury Molecule 1 (KIM-1) ELISA Kit is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Kidney Injury Molecule 1 (KIM-1) ELISA Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Kidney Injury Molecule 1 (KIM-1) ELISA Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Kidney Injury Molecule 1 (KIM-1) ELISA Kit players cover Elabscience Biotechnology Inc., Crystal Chem, Wuhan Fine Biotech Co., Ltd., MyBiosource, Inc. and Shanghai Korain Biotech Co., Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage

This latest report provides a deep insight into the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market, with both quantitative and qualitative data, to help readers understand how the Kidney Injury Molecule 1 (KIM-1) ELISA Kit market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:

The study segments the Kidney Injury Molecule 1 (KIM-1) ELISA Kit market and forecasts the market size by Type (Human, Mouse and Rat), by Application (Hospital, Research Institute and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Human
Mouse
Rat
Porcine
Other
Segmentation by application
Hospital
Research Institute
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Elabscience Biotechnology Inc.
Crystal Chem
Wuhan Fine Biotech Co., Ltd.
MyBiosource, Inc.
Shanghai Korain Biotech Co., Ltd.
​​Abcam
Enzo Life Sciences, Inc.
CUSABIO
CLOUD-CLONE CORP.
Creative Diagnostics
Bio-Techne
Innovative Research
RayBiotech, Inc.
Assay Genie
Cepham Life Sciences, Inc
Abbexa
Geno Technology, Inc.
ZodelBiotec Ltd.

Chapter Introduction
Chapter 1: Scope of Kidney Injury Molecule 1 (KIM-1) ELISA Kit, Research Methodology, etc.
Chapter 2: Executive Summary, global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market size (sales and revenue) and CAGR, Kidney Injury Molecule 1 (KIM-1) ELISA Kit market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Kidney Injury Molecule 1 (KIM-1) ELISA Kit sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Elabscience Biotechnology Inc., Crystal Chem, Wuhan Fine Biotech Co., Ltd., MyBiosource, Inc., Shanghai Korain Biotech Co., Ltd., ​​Abcam, Enzo Life Sciences, Inc., CUSABIO and CLOUD-CLONE CORP., etc.
Chapter 14: Research Findings and Conclusion

Please note: The report will take approximately 2 business days to prepare and deliver.